| Contributors |
|
xvii | |
| Preface |
|
xxiii | |
|
Naturally Occurring Aminophosphonic and Aminophosphinic Acids |
|
|
1 | (32) |
|
|
|
|
|
|
|
|
|
|
|
2-Aminoethanephosphonic acid (AEP, ciliatane) |
|
|
2 | (6) |
|
Phosphonates metabolically related to 2-aminoethanephosphonic acid |
|
|
8 | (1) |
|
Aminophosphonate antibiotics and related compounds |
|
|
9 | (1) |
|
Antibiotic phosphonopeptides |
|
|
10 | (5) |
|
Biosynthesis of the P--C bond |
|
|
15 | (2) |
|
Biosynthesis of 2-aminoethanephosphonic acid and its N-methylated derivatives |
|
|
17 | (1) |
|
Biosynthesis of bialaphos |
|
|
18 | (1) |
|
Biodegradation of organophosphonates |
|
|
18 | (4) |
|
The origin of aminophosphonates in nature |
|
|
22 | (1) |
|
|
|
23 | (10) |
|
Synthesis of α-Aminoalkanephosphonic and α-Aminoalkanephosphinic Acids |
|
|
33 | (42) |
|
|
|
|
|
|
|
|
|
|
|
Aldehydes and ketones as substrates for the preparation of aminophosphonates |
|
|
34 | (16) |
|
Amidolkylation of trivalent phosphorus compounds |
|
|
34 | (3) |
|
Mannich-type condensation of amines with aldehydes and phosphorous or hypophosphorous acid |
|
|
37 | (1) |
|
Kabachnik-Fields reaction |
|
|
38 | (3) |
|
Hydrophosphonylation of imines |
|
|
41 | (3) |
|
Hydrophosphonylation of other C=N bonds |
|
|
44 | (2) |
|
Hydrophosphonylation of triazines |
|
|
46 | (1) |
|
Hydrophosphonylation of aldehydes-hydroxyalkanephosphonates as substrates for the preparation of 1-aminoalkanephosphonates |
|
|
47 | (3) |
|
Carboxylic acids as substrates for the synthesis of 1-aminoalkanephosphonic acids |
|
|
50 | (5) |
|
1-Oxoalkanephosphonates as substrates |
|
|
50 | (3) |
|
Phosphonoacetates as substrates |
|
|
53 | (1) |
|
Replacement of amino acid carboxylic moieties by phosphonic groups |
|
|
54 | (1) |
|
|
|
55 | (1) |
|
Phosphonylation of halogenoalkylamines and related compounds |
|
|
56 | (3) |
|
Amination of alkanephosphonates and functionalized alkanephosphonates |
|
|
59 | (2) |
|
|
|
59 | (1) |
|
|
|
60 | (1) |
|
Alkylation of derivatives of dialkyl aminomethanephosphonates |
|
|
61 | (3) |
|
Alkylation of Schiff bases |
|
|
61 | (1) |
|
Alkylation of other derivatives of aminomethanephosphonic acid |
|
|
62 | (2) |
|
Hydrogenation of N-acyl-α, β-dehydroaminophosphonates |
|
|
64 | (1) |
|
|
|
64 | (3) |
|
Hydrolytic cleavage of carbon-phosphorus bond |
|
|
67 | (1) |
|
|
|
67 | (8) |
|
Synthesis of Aminoalkanephosphonic and Aminoalkanephosphinic Acids with the Amino Substituent in other than the α-Position |
|
|
75 | (28) |
|
|
|
|
|
|
Synthesis of ω-aminophosphonates by addition of amines to unsaturated phosphonates |
|
|
76 | (2) |
|
Introduction of the amino function by ketophosphonate transformation |
|
|
78 | (4) |
|
Formation of the amino function in phosphonates by reduction of nitrogen-containing groups |
|
|
82 | (1) |
|
Syntheses of aminophosphonates by the Arbuzov and Michaelis--Becker reactions |
|
|
83 | (2) |
|
Synthesis of aminoalkanephosphonic acids by Curtius and Hofmann rearrangements |
|
|
85 | (1) |
|
Syntheses of aminophosphonates by the carbanion approach |
|
|
86 | (2) |
|
Miscellaneous reactions leading to aminophosphonates |
|
|
88 | (4) |
|
Arenephosphonic acids containing an amino function in the ring |
|
|
92 | (2) |
|
Nitrogen heterocycles with a phosphonic (or phosphinic) acid residue |
|
|
94 | (5) |
|
|
|
99 | (4) |
|
α-Amino Acid Analogues Bearing Side-Chain C-P Linkages |
|
|
103 | (24) |
|
|
|
|
|
|
|
|
|
|
|
|
|
103 | (1) |
|
Syntheses and biological significance |
|
|
104 | (1) |
|
Analogues of biological α-amino acids |
|
|
104 | (11) |
|
|
|
104 | (2) |
|
Syntheses of analogues of phosphinothricin |
|
|
106 | (3) |
|
Other potentially useful analogues of phosphinothricin |
|
|
109 | (1) |
|
Analogues of glutamic and aspartic acid--structure |
|
|
110 | (1) |
|
Analogues of glutamic and aspartic acid--syntheses and biology |
|
|
110 | (5) |
|
Analogues of amino acid phosphate esters |
|
|
115 | (4) |
|
|
|
115 | (1) |
|
Analogues of amino acid phosphate esters--synthesis |
|
|
116 | (3) |
|
Other α-amino acids containing a C-P bond in the side-chain |
|
|
119 | (1) |
|
Analogues of phosphatidylserine |
|
|
120 | (1) |
|
Consideration for future studies |
|
|
121 | (1) |
|
|
|
122 | (5) |
|
Asymmetric Synthesis of Aminophosphonic and Aminophosphinic Acids |
|
|
127 | (46) |
|
|
|
|
|
|
Enantioselective C--C Bond forming reactions |
|
|
128 | (15) |
|
Chiral `glycine' synthons--chirality in the nitrogen residue |
|
|
128 | (9) |
|
Chiral `glycine' synthons--chirality in the phosphorus residue |
|
|
137 | (2) |
|
Catalyzed C--C bond formation reaction leading to chiral aminophosphonates |
|
|
139 | (1) |
|
Miscellaneous C--C bond formation reactions leading to chiral aminophosphonates |
|
|
140 | (3) |
|
Enantioselective C--P bond forming reactions |
|
|
143 | (11) |
|
Addition of hydrophosphonyl compounds to imines |
|
|
143 | (5) |
|
Three-component Kabachnik--Fields reaction |
|
|
148 | (3) |
|
Catalytic addition of hydrophosphonyl compounds to C=N bonds |
|
|
151 | (1) |
|
Miscellaneous reactions for stereoselective C--P bond formation |
|
|
152 | (2) |
|
Stereoselective C--N bond formation |
|
|
154 | (10) |
|
Steroselective C--H bond forming reactions |
|
|
164 | (3) |
|
|
|
167 | (1) |
|
|
|
168 | (5) |
|
Synthesis of Phosphono-and Phosphinopeptides |
|
|
173 | (32) |
|
|
|
|
|
|
|
|
|
|
|
Protection of the amino group |
|
|
174 | (2) |
|
Protection of the phosphonic moiety |
|
|
176 | (2) |
|
Synthesis of phosphono-and phosphinopeptides containing P-terminal aminophosphonate |
|
|
178 | (5) |
|
Preparation of diastereomeric phosphonodipeptides containing P-terminal aminophosphonate |
|
|
183 | (1) |
|
Phosphonodepsipeptides containing P-terminal hydroxyphosphonate |
|
|
183 | (1) |
|
Peptides containing a phosphonic or phosphinic moiety in the side-chain |
|
|
184 | (3) |
|
Peptides containing a phosphonamide or phosphinamide bond |
|
|
187 | (4) |
|
Phosphonodepsipeptides containing a phosphonoester moiety |
|
|
191 | (2) |
|
Phosphinopeptide nucleic acids |
|
|
193 | (1) |
|
Phosphinopeptides in which a phosphinic acid replaces a dipeptidyl fragment of the peptide chain |
|
|
194 | (2) |
|
Peptides in which a PH2 group replaces the NH2 moiety |
|
|
196 | (1) |
|
|
|
196 | (9) |
|
Column Chromatography of Aminophosphonic Acids and Phosphonopeptides |
|
|
205 | (12) |
|
|
|
|
|
|
|
|
205 | (1) |
|
Separation of phosphonopeptides using column liquid chromatography |
|
|
206 | (1) |
|
Chiral recognition of aminophosphonic acids |
|
|
207 | (6) |
|
Derivatization of aminophosphonic acids for HPLC analysis |
|
|
213 | (1) |
|
Derivatization of aminophosphonic acids for gas chromatographic analysis |
|
|
214 | (1) |
|
Optimization and problem solving |
|
|
215 | (1) |
|
|
|
215 | (2) |
|
Physical Properties and NMR-Spectroscopic Characterization of Aminophosphonates and Aminophosphinates |
|
|
217 | (68) |
|
|
|
|
|
|
|
|
217 | (2) |
|
The 1H-NMR spectrum of α-N-phenylamino-α-phenylmethanephosphonic acid diethyl ester |
|
|
219 | (14) |
|
|
|
219 | (3) |
|
|
|
222 | (1) |
|
|
|
223 | (3) |
|
Aromatic ring current effects and molecular structure |
|
|
226 | (7) |
|
1H-, 19F-and 31 P-NMR spectra of aromatic substitutents Ar1 and Ar2 and related fragments in α-N-arylamino-α-arylmethanephosphonic acid diethyl esters |
|
|
233 | (1) |
|
Increasing complexity by sterically demanding aromatic substituents in Ar1 or Ar2 |
|
|
234 | (8) |
|
The 1-naphthyl group attached to the CHP unit |
|
|
234 | (3) |
|
The 2-naphthyl group attached to the CHP unit |
|
|
237 | (2) |
|
The 9-anthryl group attached to the CHP unit |
|
|
239 | (1) |
|
The 1-naphthyl group attached to the NH unit |
|
|
240 | (2) |
|
Sterically overcrowded aminophosphonates |
|
|
242 | (4) |
|
Variations of 1H-NMR spectra from-CHP-NH-fragments with substituent pattern, temperature, solvent and protonation |
|
|
246 | (14) |
|
α-N-(4-fluorophenyl)amino-α-phenylmethanephosphonic acid diethyl ester |
|
|
246 | (5) |
|
Classification of-CHP-NH-spectra |
|
|
251 | (1) |
|
Attempts to interpret the results |
|
|
251 | (2) |
|
Conformational analysis of α-N-(4-trifluoromethylphenyl)amino-α-phenylmethanephosphonic acid diethyl ester |
|
|
253 | (6) |
|
Bulky aromatic substituents in Ar1 and Ar2 |
|
|
259 | (1) |
|
Heterocyclic aminophosphonates |
|
|
260 | (2) |
|
Aromatic ring current effects in an isomeric pair of naphthyl-substituted aminophosphonates |
|
|
262 | (3) |
|
Bifunctional aminophosphonates |
|
|
265 | (4) |
|
Structural considerations |
|
|
265 | (1) |
|
The CHP-skeleton of bifunctional aminophosphonates |
|
|
265 | (2) |
|
The P(O) (OCH3)2 groups from bifunctional aminophosphonates |
|
|
267 | (2) |
|
|
|
269 | (7) |
|
Solid state and molecular modelling of P-[α-N-(4-fluorophenyl)-amino-α-phenylmethyl]-P-(methyl) phosphinic acid n-butyl ester (2.1-D1) |
|
|
271 | (3) |
|
The 1H-NMR spectrum of P-[α-N-(4-fluorophenyl) amino-α-phenyl-methyl]-P-(methyl)phosphinic acid n-butyl ester (2.1-D1) |
|
|
274 | (2) |
|
Some comments on phosphonic and phosphinic acids |
|
|
276 | (4) |
|
|
|
280 | (5) |
|
Structure and Stability Constants of Metal Complexes in Solution |
|
|
285 | (42) |
|
|
|
|
|
|
|
|
|
|
|
|
|
285 | (1) |
|
Phosphonic derivatives of amino acids and related compounds |
|
|
286 | (11) |
|
|
|
286 | (1) |
|
Metal-binding capabilities |
|
|
287 | (10) |
|
Phosphono derivatives of dipeptides |
|
|
297 | (1) |
|
Open-chain aminopolyphosphonates |
|
|
298 | (8) |
|
Macrocyclic aminophosphonates and aminophosphinates |
|
|
306 | (15) |
|
|
|
309 | (3) |
|
|
|
312 | (5) |
|
|
|
317 | (1) |
|
MRI contrast enhancement materials |
|
|
317 | (2) |
|
Diagnostic use of fluorescent complexes |
|
|
319 | (1) |
|
Paramagnetic complexes as shift reagents |
|
|
320 | (1) |
|
Determination of intracellular metal ion concentration |
|
|
320 | (1) |
|
Radioimmunoassay techniques |
|
|
320 | (1) |
|
|
|
321 | (1) |
|
|
|
321 | (1) |
|
|
|
321 | (6) |
|
X-Ray Crystallographic Studies |
|
|
327 | (36) |
|
|
|
|
|
|
|
|
|
|
|
|
|
327 | (18) |
|
Mono(aminophosphonic) and mono (aminophosphinic) acids |
|
|
345 | (4) |
|
N-Acylated aminophosphonic and aminophosphinic acids |
|
|
349 | (2) |
|
Diphosphonic and diphosphinic acids |
|
|
351 | (1) |
|
|
|
351 | (1) |
|
Tetraphosphonic and tetraphosphinic acids |
|
|
352 | (7) |
|
|
|
359 | (4) |
|
Mass Spectrometry and Gas Chromatography-Mass Spectrometry of Aminoalkanephosphonic Acids |
|
|
363 | (44) |
|
|
|
|
|
|
|
|
|
|
|
|
|
363 | (1) |
|
Derivatization of aminophosphonic acids and related compounds for GC and GC/MS |
|
|
364 | (8) |
|
Mass spectrometric characterization of derivatized aminoalkanephosphonic acids and related copounds |
|
|
372 | (13) |
|
Mass spectrometric characterization of O,O-substituted aminoalkanephosphonic acids |
|
|
372 | (1) |
|
Mass spectrometric characterization of TMS-derivatives of aminoalkanephosphonates |
|
|
372 | (2) |
|
Mass spectrometric characterization of O,O-dialkyl derivatives of aminoalkanephosphonates |
|
|
374 | (2) |
|
Mass spectrometric characterization of O,O-dialkyl 1-(N-acylamino)-alkanephosphonates |
|
|
376 | (1) |
|
Mass spectrometric characterization of O,O-dialkyl 1-(N-formylamino)-alkanephosphonates |
|
|
377 | (2) |
|
Mass spectrometric characterization of O,O-dialkyl 1-(N-acetylamino)-alkanephosphonates |
|
|
379 | (1) |
|
Mass Spectrometic Characterization of O,O-Dialkyl 1-(N-trifluoroacetylamino)-alkanephosphonates |
|
|
379 | (3) |
|
Mass spectrometric characterization of other types of N-acylaminoalkanephosphonates |
|
|
382 | (1) |
|
Chemical ionization mass spectrometry of O,O-dialkyl 1-(N-acylamino)alkanephosphonates |
|
|
382 | (3) |
|
Mass spectrometric characterization of underivatized aminoalkanephosphonic acids, partly protected aminoalkanephosphonic acids and related derivatives |
|
|
385 | (10) |
|
Mass spectra of underivatized aminoalkanephosphonic acids |
|
|
385 | (1) |
|
Chemical ionization mass spectra of aminoalkanephosphonic acids |
|
|
385 | (3) |
|
Fast atom bombardment mass spectra of amino-and guanidino-alkanephosphonic acids |
|
|
388 | (2) |
|
Mass spectra of N-acylaminoalkanephosphonic acids |
|
|
390 | (5) |
|
Mass spectrometric characterization of phosphonopetides |
|
|
395 | (9) |
|
EI mass spectra of protected phosphonopeptides |
|
|
397 | (2) |
|
FAB mass spectra of protected phosphonopeptides |
|
|
399 | (2) |
|
FAB mass spectra of unprotected phosphonopeptides |
|
|
401 | (3) |
|
|
|
404 | (3) |
|
The Biological Activity of Phosphono-and Phosphinopeptides |
|
|
407 | (36) |
|
|
|
|
|
|
|
|
|
|
|
Antibacterial phosphonopeptides |
|
|
408 | (3) |
|
|
|
411 | (16) |
|
Inhibitors of serine proteases |
|
|
412 | (5) |
|
Inhibitors of metalloproteases |
|
|
417 | (8) |
|
Inhibitors of aspartic proteases |
|
|
425 | (1) |
|
Inhibitors of cysteine proteases |
|
|
426 | (1) |
|
Inhibitors of β-lactamase |
|
|
427 | (1) |
|
|
|
427 | (1) |
|
Inhibitors of phosphotyrosyl-dependent signal transduction |
|
|
428 | (3) |
|
Analogues of methotrexate |
|
|
431 | (3) |
|
|
|
434 | (1) |
|
Catalytic antibodies (abzymes) |
|
|
434 | (1) |
|
|
|
435 | (8) |
|
Aminophosphonic and Aminophosphinic Acids and their Derivatives as Agrochemicals |
|
|
443 | (40) |
|
|
|
|
|
|
|
|
443 | (1) |
|
Commercially available agrochemicals and their analogues |
|
|
444 | (10) |
|
|
|
445 | (4) |
|
Glufosinate and Bilanafos |
|
|
449 | (5) |
|
Related Aminocarbonylphosphonic Acids |
|
|
454 | (1) |
|
Biologically active aminophosphonic and aminophosphinic acids as candidate agrochemicals |
|
|
454 | (20) |
|
|
|
454 | (1) |
|
Plant-growth Regulators and Herbicides |
|
|
455 | (1) |
|
Aminoalkane-phosphonic and-phosphinic acids |
|
|
455 | (3) |
|
Aminocycloalkyl-phosphonic acids and-phosphine oxides |
|
|
458 | (1) |
|
N-Arylaminoalkyl-phosphonates,-phosphinates, and-phosphine oxides |
|
|
458 | (1) |
|
Amino(aryl)alkyl-phosphonic and-phosphinic acids |
|
|
459 | (2) |
|
Phosphono-and phosphinopeptides |
|
|
461 | (1) |
|
N-Phosphonoacetylamines, guanidino derivatives, and isoxazole-substituted aminoethylphosphonates |
|
|
462 | (1) |
|
Aminomethylenebisphosphonic acids |
|
|
463 | (2) |
|
|
|
465 | (1) |
|
|
|
465 | (1) |
|
N-(ω-Guanidinoalkyl)-and N-(ω-aminoalkyl)-aminoalkane-phosphonic and-phosphinic acids |
|
|
466 | (1) |
|
Aminoalkane-phosphonic and-phosphinic acids |
|
|
467 | (2) |
|
Amino(aryl)alkyl-phosphonic and-phosphinic acids |
|
|
469 | (1) |
|
|
|
470 | (1) |
|
Insecticides and related compounds |
|
|
471 | (1) |
|
|
|
472 | (2) |
|
|
|
474 | (1) |
|
|
|
474 | (9) |
|
Neuroactive Aminophosphinic and Aminophosphinic Acid Derivatives |
|
|
483 | (54) |
|
|
|
|
|
|
|
|
483 | (1) |
|
Ionotropic glutamate receptors |
|
|
484 | (21) |
|
|
|
484 | (2) |
|
The NMDA receptor complex |
|
|
486 | (1) |
|
|
|
487 | (1) |
|
|
|
488 | (2) |
|
Competitive NMDA receptor antagonists |
|
|
490 | (4) |
|
Radioligands for the glutamate recognition site of the NMDA receptor |
|
|
494 | (1) |
|
Molecular modelling studies |
|
|
494 | (1) |
|
Subtype selectivity of competitive NMDA receptor antagonists |
|
|
495 | (1) |
|
Antagonists binding to the glycine co-agonist site of the NMDA receptor |
|
|
496 | (1) |
|
Therapeutic applications of NMDA receptor antagonists |
|
|
497 | (1) |
|
AMPA and kainate receptors |
|
|
498 | (3) |
|
AMPA and kainate receptor agonists |
|
|
501 | (1) |
|
AMPA and kainate receptor antagonists |
|
|
501 | (3) |
|
Therapeutic utility of AMPA and kainate antagonists |
|
|
504 | (1) |
|
Metabotropic glutamate receptors |
|
|
505 | (11) |
|
|
|
505 | (3) |
|
Group I selective agonists and antagonists |
|
|
508 | (2) |
|
Group II selective agonists and antagonists |
|
|
510 | (1) |
|
Group III selective agonists and antagonists |
|
|
511 | (4) |
|
|
|
515 | (1) |
|
Phospholipase D coupled mGlu receptors |
|
|
516 | (1) |
|
Therapeutic utility of mGlu receptor agonists and antagonists |
|
|
516 | (1) |
|
Gaba receptor pharmacology |
|
|
516 | (9) |
|
|
|
516 | (1) |
|
GABAB receptor agonists and antagonists |
|
|
517 | (4) |
|
GABAC receptor agonists and antagonists |
|
|
521 | (2) |
|
|
|
523 | (1) |
|
Antagonists of the strychnine-sensitive glycine receptor |
|
|
524 | (1) |
|
|
|
525 | (1) |
|
|
|
525 | (1) |
|
|
|
526 | (11) |
|
Aminophosphonic and Aminophosphinic Acid Derivatives in the Design of Transition State Analogue Inhibitors: Biomedical Opportunities and Limitations |
|
|
537 | (22) |
|
|
|
|
|
|
Proteolytic Enzymes: classification, mechanism of the proteolysis and implication for the design of transition analogue inhibitors |
|
|
539 | (2) |
|
|
|
541 | (3) |
|
Proteolytic enzymes as targets for drug design |
|
|
544 | (2) |
|
Serine proteinases as targets for drug design. Biomedical opportunities for derivatives of α-aminoalkylphosphonic acid diphenyl esters |
|
|
546 | (3) |
|
Human neutrophil elastase (HNE) |
|
|
549 | (1) |
|
Dipeptidyl peptidase IV (DPP IV/D26) |
|
|
550 | (2) |
|
|
|
552 | (1) |
|
Human cytomegalovirus protease |
|
|
553 | (1) |
|
|
|
553 | (2) |
|
Proteolytic enzymes from larvae of the fire ant, Solenopsis invicta |
|
|
555 | (1) |
|
|
|
556 | (3) |
|
Aminophosphonic and Aminophosphinic Acids in the Design and Synthesis of HIV Protease Inhibitors |
|
|
559 | (20) |
|
|
|
|
|
|
|
|
559 | (2) |
|
Linear Inhibitors of HIV protease |
|
|
561 | (4) |
|
C2-Symmetric Inhibitors of HIV protease |
|
|
565 | (8) |
|
Non-peptide inhibitors of HIV protease |
|
|
573 | (2) |
|
|
|
575 | (1) |
|
|
|
575 | (4) |
|
Aminophosphonic Acid Derivatives as Antithrombotic Agents |
|
|
579 | (18) |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
579 | (2) |
|
Studies of the Mechanism of Inhibition of Thrombin by Peptidylphosphonates |
|
|
581 | (2) |
|
Routes to Dialkyl and Diaryl α-Aminophosphonates as Precursors for Thrombin Inhibitors |
|
|
583 | (1) |
|
Tripeptidylphosphonates as Thrombin Inhibitors |
|
|
584 | (2) |
|
Determination of Ki and Mechanism of Inhibition of Thrombin |
|
|
586 | (1) |
|
Kinetics of the Slow Binding Phase (k2, k-2, and ki,) of Thrombin Inhibition by Z-Dpa-Pro-MpgP (OPH)2 |
|
|
586 | (1) |
|
Fitting generated values for A0 (initial absorbance), Vo (initial velocity), and Vs (final steady state velocity) |
|
|
587 | (2) |
|
Specificity of Z-Dpa-Pro-MpgP (OPh)2 for Thrombin |
|
|
589 | (1) |
|
Analysis of the Interaction of Z-D-Dpa-Pro-MpgP (OPh)2 with Human Thrombin by Crystallography |
|
|
590 | (2) |
|
O,O-Dialkyl Dipeptidyl-ψ-(carboxy) benzylphosphonates as Novel Thrombin Inhibitors |
|
|
592 | (2) |
|
|
|
594 | (1) |
|
|
|
594 | (3) |
|
Aminophosphonic and Aminophosphinic Acid Derivatives as Inhibitors of Human Collagenase |
|
|
597 | (24) |
|
|
|
|
|
|
Human collagenase (MMP-1) and the matrix metalloproteinase (MMP) family |
|
|
597 | (1) |
|
Potential therapeutic indications for MMP inhibitors |
|
|
598 | (1) |
|
Structural characterisation of the MMP's |
|
|
598 | (1) |
|
Design of collagenase inhibitors |
|
|
599 | (1) |
|
Aminophosphonic acid derivatives as collagenase inhibitors |
|
|
600 | (6) |
|
Proposed binding of an aminophosphonic acid inhibitor to collagenase (MMP-1) |
|
|
606 | (3) |
|
Aminophosphinic acid derivatives as collagenase inhibitors |
|
|
609 | (6) |
|
Comparison of aminophosphonic acid based inhibitors with other structural types |
|
|
615 | (2) |
|
|
|
617 | (4) |
| Index |
|
621 | |